Taking "no relevant effect" limits of 80 to 125% for primaquine exposure (with or without pyronaridine-artesunate) and assuming a within-subject coefficient of variation for primaquine exposure of 21% (10), a sample size of 16 subjects (8 per sequence) provided statistical power of approximately 80%.
Taking 80 to 125% as the no-relevant-effect limits for primaquine exposure (with or without dihydroartemisinin), and assuming a within-subject coefficient of variation for primaquine AUC of 21% (8), a sample size of 16 subjects (8 per sequence) provided a statistical power of 80%.
To qualify for the Charter ASP logo, products must successfully pass an environmental safety check (ESC [3]), which means that all ingredients have to be below a no-effect limit for aquatic toxicity.
Doxorubicin hydrochloride (DOX·HCl), have been reported with a widespread applications in ovarian, breast and lung cancer as well as malignant lymphoma [1, 2] however, the cardiotoxicity associated side effect limits its long term use for such clinical purposes [3, 4].
The groups often work in concert with private schools like Gwinnett Christian Academy to solicit donations and determine who will get the scholarships — in effect limiting school choice for the students themselves.
However, the Raman process is a weak effect, limiting its application for fast chemical imaging of a living system.
While both are susceptible to supercooling, the effect is limited for odd ones, but much larger for the even ones [44], an observation that we already earlier made from ASC data for C24 [46].
However, the additional cleanup effect was limited for the fuel oil samples (Electronic supplementary material Fig. S 2B).
The effect was limited for milk spiked with penicillin G (4 μg kg−1) and cloxacillin (12 μg kg−1), but more visible for ampicillin (6 μg kg−1).
Additionally, the fact that t'ai chi interventions cannot control for placebo effects limits generalisability.
Due to the potential health effects, maximum residue limits for these compounds have been established in milk and tissues intended for human consumption, whilst the application of glucocorticoids as growth promoters is banned in the European Union [ 25– 27].
